Researchers have compared prevalence of aquaporin-4 in the brains of those who had Alzheimer’s to those who didn’t have the disease, and report that they may have found a new target for treating and preventing the disease.
Researchers have compared prevalence of aquaporin-4 in the brains of those who had Alzheimer’s to those who didn’t have the disease, and report that they may have found a new target for treating and preventing the disease.